Biotechnology company Amgen Inc on Thursday said its third-quarter revenue rose 1% as higher volume growth for its cancer, rheumatology and cardiovascular products was offset by lower prices and foreign exchange losses.
Two Spanish poultry farm workers tested positive for bird flu following an outbreak in poultry, in what appears to be the first known human infections in Spain and the second in Europe since 2003, the World Health Organization said on Thursday.
Qatari medical practitioners will not ask patients about their marital status, religion or any other status when providing medical care during the world cup, a healthcare spokesperson said on Thursday.
Teva Pharmaceuticals will pay up to $4.2 billion in the United States to settle claims related to its role in fueling the country's opioid crisis, New York Attorney General Letitia James said on Thursday.
Teva Pharmaceutical Industries Ltd will pay up to $523 million to New York State as part of a nationwide settlement of lawsuits alleging the company helped fuel the U.S. opioid epidemic.
The death toll from an Ebola outbreak in Uganda has risen to 48, with 131 confirmed cases, a health official involved in managing the outbreak said on Thursday.
Moderna Inc on Thursday cut its 2022 COVID-19 vaccine sales forecast, citing regulatory and production delays, and issued a 2023 outlook for the shots well below Wall Street estimates, and its shares fell as much as 9% before recovering.
U.S. drugmaker Pfizer Inc and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.
Cigna Corp on Thursday raised its annual adjusted profit forecast for the third time after beating quarterly estimates on the back of strength in the health insurer's Evernorth unit that houses its pharmacy benefit management business.
Several of China's largest medical testing companies have posted big increases in profit for the first three quarters of the year, as the country's strict zero-COVID policy boosts spending in a minority of sectors while depressing the broader economy.
